Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
advertise
Legal Help
login/register
You are here
Home
»
companies
» Vosevi
Vosevi
FDA issues safety warning for newer hepatitis C drugs following patient deaths
FDA issues safety warning for newer hepatitis C drugs following patient deaths
Biopharma Dive
FDA
hepatitis C
FAERS
AbbVie
Mavyret
Merck
Zepatier
Gilead Sciences
Vosevi
Flag link:
Gilead Has Another Ace Up Its Sleeve
Gilead Has Another Ace Up Its Sleeve
Seeking Alpha
Gilead Sciences
hepatitis C
Vosevi
Flag link:
FDA's Flashing Green Light Boosts Novel Drug Approvals
FDA's Flashing Green Light Boosts Novel Drug Approvals
Seeking Alpha
FDA
drug approvals
Gilead Sciences
Puma Biotechnology
Vosevi
Nerlynx
Flag link:
How AbbVie Could Hammer Gilead's Hepatitis C Franchise
How AbbVie Could Hammer Gilead's Hepatitis C Franchise
Investors Business Daily
AbbVie
Gilead Sciences
hepatitis C
Vosevi
Harvoni
Sovaldi
Epclusa
Viekira Pak
Flag link:
FDA OKs a new triple hep C drug from Gilead, keeping its grip on a shrinking market
FDA OKs a new triple hep C drug from Gilead, keeping its grip on a shrinking market
Endpoints
Gilead Sciences
FDA
hepatitis C
Vosevi
Flag link:
EMA Recommends New HCV, Cancer and MS Drugs for Approval
EMA Recommends New HCV, Cancer and MS Drugs for Approval
RAPS.org
Europe
EMA
hepatitis C
multiple sclerosis
breast cancer
renal cell carcinoma
AbbVie
Maviret
Gilead Sciences
Vosevi
Biogen
Amgen
Samsung Bioepis
biosimilars
Humira
Novartis
Kisqali
EUSA
Fotivda
Flag link:
